Months after suspending work, the Food and Drug Administration “has resumed its first-ever endeavor to evaluate how much of a controversial chemical is making its way into the U.S. food supply,” says a blog post by Carey Gillam of U.S. Right to Know. The FDA began the “special assignment” last year but stopped the work… » Read More